Search results
Factor XII Deficient Plasma
Measurement of factor XII (FXII or factor hageman) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FXII deficient plasma is required.
Factor XI Deficient Plasma
Measurement of Factor XI (FXI or factor rosenthal) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FXI deficient plasma is required
Factor XI Deficient Plasma
Measurement of factor XI (FXI or factor rosenthal) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FXI deficient plasma is required
Factor X Deficient Plasma
Measurement of factor X (FX or stuart factor) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human FX deficient plasma is required
CRYOcheck Factor II (Prothrombin) Deficient Plasma, frozen
Deficient substrate for clot-based factor II assays.
Factor II (Prothrombin) Deficient Plasma
Measurement of factor II (FII / prothrombin) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human prothrombin deficient plasma is required.
Factor II (Prothrombin) Deficient Plasma
Measurement of Factor II (FII / prothrombin) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human prothrombin deficient plasma is required.
(h)PT-Phen (PT reagent, recombinant)
Determination of prothrombin time (PT) in human citrated plasma.
Platelet lysate 4, Human
High purity preparation, in the tetrameric form, tested for its anti-heparin activity. In presence of heparin, this product offers an optimized binding capacity for heparin dependent antibodies developed in HIT (heparin induced thrombocytopenia).
Protac® Protein C Activator
For activation of protein C.